SEARCH HEALTH CONDITIONS BY ALPHABETS
Systemic Mastocytosis
Medications for Systemic Mastocytosis
Other titles: Mastocytosis, Systemic; Systemic Mast Cell Disease
About Systemic Mastocytosis: Systemic mastocytosis is a disorder where there is an increased number of mast cells within your skinand bone marrow and organs such as liver, spleenand lymph nodes and gastro intestinal tract. The symptom severity varies from being mild to life threatening based on regions of the body which can be influenced. Symptoms can include skin reactions, including blood disorders liver, spleen or lymph nodes gastrointestinal effects such as nausea diarrhea or vomiting.
Drugs Used to Address Systemic Mastocytosis
The following listing of medications have been used in the treating this illness, or in some way associated with.
| Drug title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| cromolyn | Rx | B | N | 5 testimonials | 8.4 | ||
Generic title: cromolyn systemic Brand title: Gastrocrom Drug class: mast cell stabilizers For consumers: dosage, interactions, For professionals: a Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
| Gastrocrom | Rx | B | N | 2 testimonials | 8.6 | ||
Generic title: cromolyn systemic Drug class: mast cell stabilizers For consumers: dosage, interactions, and side effects For professionals: Prescribing Information | |||||||
| omeprazole | Rx/OTC | C | N | Add inspection | 0.0 | ||
Generic title: omeprazole systemic Brand title: Prilosec Drug course: proton pump inhibitors For consumers: dosage, interactions, For professionals: a Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
| Gleevec | Rx | D | N | Add inspection | 0.0 | ||
Generic title: imatinib systemic Drug course: BCR ABL tyrosine kinase inhibitors For consumers: dosage, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| Prilosec | Rx | C | N | Add inspection | 0.0 | ||
Generic title: omeprazole systemic Drug course: proton pump inhibitors For consumers: dosage, interactions, and side effects For professionals: Prescribing Information | |||||||
| lansoprazole | Rx/OTC | B | N | Add inspection | 0.0 | ||
Generic title: lansoprazole systemic Brand titles: Prevacid, Prevacid OTC, Prevacid SoluTab Drug course: proton pump inhibitors For consumers: dosage, interactions, For professionals: a Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
| imatinib | Rx | D | N | Add inspection | 0.0 | ||
Generic title: imatinib systemic Brand title: Gleevec Drug course: BCR ABL tyrosine kinase inhibitors For consumers: dosage, interactions, For professionals: a Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
| midostaurin | Rx | N | 3 testimonials | 8.3 | |||
Generic title: midostaurin systemic Brand title: Rydapt Medicine class: multikinase inhibitors For consumers: dosage, interactions, For professionals: a Z Drug Truth, AHFS DI Monograph | |||||||
| Prevacid | Rx | B | N | Add inspection | 0.0 | ||
Generic title: lansoprazole systemic Drug course: proton pump inhibitors For consumers: dosage, interactions, and side effects For professionals: Prescribing Information | |||||||
| Rydapt | Rx | N | 2 testimonials | 7.5 | |||
Generic title: midostaurin systemic Medicine class: multikinase inhibitors For consumers: dosage, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| Prevacid OTC | OTC | B | N | Add inspection | 0.0 | ||
Generic title: lansoprazole systemic Drug course: proton pump inhibitors For consumers: dosage, interactions, side effects | |||||||
| Prevacid SoluTab | Rx | B | N | Add inspection | 0.0 | ||
Generic title: lansoprazole systemic Drug course: proton pump inhibitors For consumers: dosage, interactions, side effects | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | On the Counter |
| Rx/OTC | Prescription or Over The Counter |
| Away Tag | This medication may well not be approved by the FDA for the treatment of this illness. |
| Pregnancy Category | |
|---|---|
| A | sufficient and well-controlled studies have failed to present a risk to the embryo within the first trimester of pregnancy (and there isn`t any evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women. |
| C | Animal reproduction studies have shown an adverse effect in the fetus and there are no sufficient and well-controlled studies in humans, but possible benefits may warrant used in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may justify used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in used in pregnant women clearly outweigh potential benefits. |
| N | FDA have not classified the drug. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | Is not subject to the Controlled Substances Act. |
| Inch | Has a high possibility of abuse. Has no currently accepted medical use in treatment in the United States. There is just a lack of accepted safety for use under medical supervision. |
| 2 | Has a high possibility of abuse. Includes a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Psychotherapy can lead to severe emotional or physical dependency. |
| 3 | Has a potential for abuse less than people in programs 1 and 2 2. Includes a currently accepted medical use in treatment in the United States. Psychotherapy can lead to moderate or low physical dependence or high psychological dependence. |
| 4 | Has a very low potential for abuse relative to people in schedule 3. It`s a currently accepted medical use in treatment in the United States. Psychotherapy can lead to limited physical dependence or psychological dependence. |
| 5 | Has a very low potential for abuse relative to people in schedule 4. Includes a currently accepted medical use in treatment in the United States. Psychotherapy can lead to limited physical dependence or psychological dependence relative to people in schedule 4. |
| Infection | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Frazee
- S
- T
- U
- V
- W
- X
- Y
- Z
Further info
Always seek advice from your physician to be sure the information pertains to your circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
